Find a Provider
  • Shu Mei Kato, MD

    Shu Mei Kato, MD

    Specialties

    • Hematology/Oncology*
    • * Indicates Board Certified in this Specialty
    760-773-4383
    Rancho Mirage
    858-822-5182
    LA JOLLA

    Location Details

    UC San Diego Health
    39000 Bob Hope Drive
    Rancho Mirage, CA 92270
    UC San Diego Health
    3855 Health Sciences Drive #0987
    LA JOLLA, CA 92093

    Shu Mei Kato, MD

    Specialties

    • Hematology/Oncology*
    • * Indicates Board Certified in this Specialty
    Shumei Kato, MD, is a Board Certified medical oncologist who specializes in treating rare cancers and gastrointestinal tumors. He uses numerous forms of therapy such as chemotherapy, biological therapy, immunotherapy and targeted therapy to offer the best possible treatment options for his patients. Dr. Kato has a special interest in targeted molecular therapy and his approach to care emphasizes personalized medicine and experimental therapeutics.

    As an assistant professor in the Department of Medicine, Dr. Kato instructs medical students, residents and fellows. His research interests include clinical trials and the design of new, more effective drugs for individualized therapy.

    Dr. Kato has coauthored peer-reviewed articles, which have been published in Nature Cell Biology and the Journal of the National Cancer Institute, among others.

    Prior to joining UC San Diego Health, Dr. Kato was an assistant professor in the Department of Investigational Cancer Therapeutics at The University of Texas, MD Anderson Cancer Center in Houston.
    Dr. Kato completed a fellowship in investigational cancer therapeutics at MD Anderson Cancer Center, a fellowship in hematology-oncology, and a fellowship in pathology at UC San Diego School of Medicine. He completed his residency training at Nippon Medical School in Tokyo, Japan and at Mount Sinai School of Medicine, Mount Sinai Beth Israel, in New York. Dr. Kato earned his medical degree from Nippon Medical School.

    He is a member of the American Society of Clinical Oncology and the American Association for Cancer Research
     

    Professional Details

    • English
    • 8 years
    • 1 years

    Professional Education

    • Nippon School of Medicine
    • Beth Israel Medical Center
    • The University of Texas MD Anderson Cancer Center
    Publication Date: April 13, 2024
CACHE